Genetics: Population Diversity, Genome India Project & Rare Diseases

UPSC Mains PYQs

Genomic Projects (2023): Explain the objectives and national significance of the Genome India Project. Discuss how population-level genetic mapping can assist in developing personalized medicine and identifying genetic disease vulnerabilities in India. (10 Marks, 150 Words)

📊 High-Yield Data & Statistical Fact Sheet

Genetics & Genomics Metrics:
- Genome India Milestone: DBT successfully completed sequencing 10,000 reference genomes representing 99% of India's population groups (endogamous communities), housed at the Indian Biological Data Centre (IBDC) in Faridabad.
- Rare Disease Burden: India has 7.0 to 9.6 Crore rare disease patients (affecting ~6% to 8% of the population); 80% have genetic origins.
- Consanguinity Risk: Marriages between close biological relatives increase risk of autosomal recessive genetic disorders by 2x to 3x.
- NPRD 2021 Financial Support: Raised financial support up to ₹50 Lakh per rare disease patient (up from ₹20 Lakh) for genetic treatments at designated Centers of Excellence.
- Sequencing Economics: Cost of sequencing a full human genome crashed from $3 Billion (HGP 2003) to under $200 in 2026.
- Population Complexity: India hosts 4,600+ distinct population groups with high endogamy, causing highly localized founder mutations.

1. GENETIC INHERITANCE & POPULATION COMPLEXITY

DNA as the Genetic Blueprint: Deoxyribonucleic Acid. Composed of four nucleotide bases: Adenine (A), Thymine (T), Guanine (G), and Cytosine (C). Specific arrangements (codons) transcribe proteins that execute cellular tasks.
Genetic Architecture of Disorders:
- Single-Gene (Mendelian) Disorders: Result from mutations in a single gene locus (e.g., Sickle Cell Anemia, Cystic Fibrosis). Ideal targets for gene-editing.
- Polygenic Disorders: Controlled by complex interactions between multiple genes and environmental triggers (e.g., hypertension, diabetes).
Consanguinity and Endogamy: Strict social endogamy across 4,600+ unique castes in India restricts gene flow, creating distinct "founder effects" that concentrate recessive disease-causing genes in specific community clusters.

Genome India Project (completed): Led by the Department of Biotechnology (DBT), sequencing 10,000 reference genomes representing all major endogamous groups across India.
National Significance:
- Reference Genomes Grid: Establishes India's first population-specific genomic reference database. Prevents clinical misdiagnoses caused by relying on Western-skewed genome models.
- Vulnerability Identification: Enables researchers to pinpoint genetic markers predisposing specific Indian sub-populations to diseases (e.g., cardiovascular vulnerability or drug metabolic traits).

National Policy for Rare Diseases (NPRD) 2021:
- Group 1: Disorders amenable to one-time curative treatment (e.g., bone marrow transplants). Eligible for up to ₹50 Lakh direct financial support.
- Group 2: Disorders requiring long-term, high-cost therapy (e.g., Gaucher's disease).
- Group 3: High-cost disorders with no definitive cure, requiring registry and trial research.
Pharmacogenomics: Integrating an individual's genetic profile with drug prescriptions to select optimal medications, adjusting dosages to fit metabolic rates and avoiding lethal Adverse Drug Reactions (ADRs).

Notes updated up to March 2026. Sources: DBT Press Release (Genome India), Ministry of Health NPRD Circulars.